Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Sertindol versus otros antipsicóticos atípicos para la esquizofrenia

Información

DOI:
https://doi.org/10.1002/14651858.CD006752.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 15 abril 2009see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Esquizofrenia

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Katja Komossa

    Correspondencia a: Klinik und Poliklinik für Psychosomatische und Medizin und Psychotherapie, Technische Universität München, Klinikum rechts der Isar, München, Germany

    [email protected]

  • Christine Rummel‐Kluge

    Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Leipzig, 04103 Leipzig, Germany

  • Heike Hunger

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Sandra Schwarz

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Franziska Schmid

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Ruth Lewis

    Department of Primary Care and Public Health, Cardiff University, Wrexham, UK

  • Werner Kissling

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

  • Stefan Leucht

    Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, München, Germany

Contributions of authors

Katja Komossa ‐ protocol development, searching, study selection, data extraction, report writing.
Christine Rummel ‐ protocol development, searching, study selection.
Stefan Leucht ‐ protocol development, searching, study selection, data extraction, report writing.
Werner Kissling ‐ protocol development.
Heike Hunger ‐ helped with data extraction and writing.
Franziska Schmid ‐ helped with data extraction and writing.
Sandra Schwarz ‐ helped with data extraction and writing.
Ruth Lewis ‐ protocol development.

Sources of support

Internal sources

  • Psychiatrische Klinik, Klinikum rechts der Isar, TU München, Freistaat Bayern, Germany.

External sources

  • Bundesministerium für Bildung und Forschung, Nr FKZ: 01KG 0606,GZ:GF‐GFKG01100506, Germany.

Declarations of interest

Katja Komossa ‐ none known.
Stefan Leucht ‐ received speaker/consultancy honoraria from Sanofi‐Aventis, BMS, Eli Lilly, Janssen, Lundbeck and Pfizer. He received research support from Sanofi‐Aventis and Eli Lilly.
Cristine Rummel ‐ received lecture honoraria and travel grants to attend scientific meetings from AstraZeneca, Janssen‐Cilag, Eli Lilly and Pfizer.
Werner Kissling: received speaker or consultancy honoraria from SanofiAventis, BMS, Lilly, Janssen, Lundbeck, Bayer and Pfizer.
Heike Hunger ‐ none known.
Franziska Schmidt ‐ none known.
Sandra Schwarz ‐ none known.
Ruth Lewis ‐ none known.

Acknowledgements

We would like to thank all members of the Cochrane Schizophrenia Group editorial team for their editorial assistance.
We would also like to thank the pharmaceutical company Lundbeck for providing additional information on the studies.

Version history

Published

Title

Stage

Authors

Version

2009 Apr 15

Sertindole versus other atypical antipsychotics for schizophrenia

Review

Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Sandra Schwarz, Franziska Schmid, Ruth Lewis, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD006752.pub2

2007 Oct 17

Sertindole versus other atypical antipsychotics for schizophrenia

Protocol

Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Sandra Schwarz, Franziska Schmidt, Ruth Lewis, Werner Kissling, Stefan Leucht

https://doi.org/10.1002/14651858.CD006752

Differences between protocol and review

The review was slightly adapted to new functions available in Review Manager 5, namely the risk of bias tables.